Results 201 to 210 of about 313,112 (301)

Molecular Simulations of Polymer‐based Drug Nanocarriers: From Physical and Structural Properties to Controlled Release

Advanced Healthcare Materials, EarlyView.
Polymer‐based drug delivery systems can effectively overcome the limitations of free drugs in terms of solubility, stability, and plasma half‐life, yet their development has traditionally relied on time‐consuming trial‐and‐error approaches. This review highlights recent advances in applying molecular simulation to the design of polymer‐based drug ...
Ping Gao, Xin Jiang, Jinyu Li, Julien Nicolas, Tâp Ha‐Duong   +4 more
wiley   +1 more source

Three-Month cART Initiated During Primary HIV Does Not Correct the Structural, Immune, and Microbial Abnormalities within the Gastrointestinal Tract. [PDF]

Pathog Immun
Tincati C, Bono V, Nozza S, Bandera A, Tosi D, Sala V, Ancona G, Calcagno A, Muscatello A, Rusconi S, Augello M, Rovito R, Gianelli U, Pescia C, Santoro A, Falleni M, Gori A, Marchetti G.   +17 more
europepmc   +1 more source

Decellularized Extracellular Matrix (dECM) in Tendon Regeneration: A Comprehensive Review

Advanced Healthcare Materials, EarlyView.
Decellularized Extracellular Matrix (dECM) offers a promising solution by replicating the native tendon microenvironment and promoting regeneration. This review highlights advances in the decellularization methods, as well as their integration with emerging technologies and translational progress in tendon tissue engineering.
Kumaresan Sakthiabirami, Yeonwoo Park, Seong Kyeong Jo, Min Hee Kim, Jae Hwang Song   +4 more
wiley   +1 more source

Prevalence of Intestinal Protozoa Among Patients Living with HIV in the Peruvian Amazon. [PDF]

Trop Med Infect Dis
Otero-Rodriguez S, Pinedo-Cancino V, Casapia-Morales M, Villacorta-Pezo VY, Mego-Campos S, Parráguez-de-la-Cruz J, Merino E, Clark EH, Ramos-Rincón JM.   +8 more
europepmc   +1 more source

Strategies to Improve the Lipophilicity of Hydrophilic Macromolecular Drugs

Advanced Healthcare Materials, EarlyView.
Hydrophilic macromolecular drugs can be successfully lipidized by covalent attachment of lipids, by hydrophobic ion pairing with negatively or positively charged surfactants, and by dry or wet reverse micelle formation. Lipophilicity enhancement of hydrophilic macromolecules has several benefits including stability and bioavailability improvement ...
Sera Lindner, Stefan Keim, Soheil Haddadzadegan, Odile Fernandez Romero, Katrin Zöller, Gabriel Stern, Ilaria Cesi, Krum Kafedjiiski, Andreas Bernkop‐Schnürch   +8 more
wiley   +1 more source

Causal association between 3 adiposity indices and 5 infectious diseases: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Chen X, Yin J, Chen C, Xiang T.
europepmc   +1 more source

Infectious intestinal disease: do we know it all?

, 2006
Charmaine Gauci, H. M. Gilles, S. O’Brien, Julian Mamo   +3 more
openalex   +1 more source

Exposure-dependent risk profiles of predominant intestinal infectious diseases across population subgroups.

Hongxin Lyu (18963049), Zhen Zhang (86004), Haozheng Zhou (16409826), Yan Ren (149348), Minhua Chen (586211), Yu Zeng (67023), Yanpeng Cheng (4379194), Huawei Xiong (18829918)   +7 more
openalex   +1 more source

Smart Catheters for Diagnosis, Monitoring, and Therapy

Advanced Healthcare Materials, EarlyView.
This study presents a comprehensive review of smart catheters, an emerging class of medical devices that integrate embedded sensors, robotics, and communication systems, offering increased functionality and complexity to enable real‐time health monitoring, diagnostics, and treatment. Abstract This review explores smart catheters as an emerging class of
Azra Yaprak Tarman, Samiha Ahmed, Majed Othman Althumayri, Megan Guy, Darlenne Chavez Lugo, Frances S. Ligler, George T. Ligler, Rahmi Oklu, Hiroshi Kawahira, Michael J. McShane, Jun Kameoka, Jonathan Bova, Hatice Ceylan Koydemir   +12 more
wiley   +1 more source

TNF signaling maintains local restriction of bacterial founder populations in intestinal and systemic sites during oral <i>Yersinia</i> infection. [PDF]

mBio
Peterson ST, Dailey KG, Hullahalli K, Sorobetea D, Matsuda R, Sewell J, Yost W, O'Neill R, Bobba S, Apenes N, Sherman ME, Balazs GI, Assenmacher C-A, Cox A, Lanza M, Shin S, Waldor MK, Brodsky IE.   +17 more
europepmc   +1 more source